Delivery Order SPE2DE24D0013-SPE2D626F480A
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,270.50 by the Defense Logistics Agency's Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 19, 2025. The delivery order, designated XPRSARS-COV2-10, is issued under a firm fixed-price contract structure with no set-aside designation. This award represents a continuation of Cepheid's established role as a primary federal supplier of molecular diagnostic solutions,...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $11,987 by the Defense Logistics Agency's Medical Supply Chain on December 11, 2025, with completion scheduled for December 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, represents a firm fixed-price procurement with no set-aside designation and utilizes a Firm Fixed Price contract structure. Based on the product designation, this delivery...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain function, awarded a $23,100 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California. The contract, designated XPRSARS-COV2-10, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order carries no set-aside designation and represents procurement of diagnostic equipment and/or reagents related to COVID-19...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 9, 2025. This delivery order, designated XPRSARS-COV2-10, is scheduled for completion by September 16, 2025, and carries no set-aside designation. The award reflects the agency's continued reliance on Cepheid's GeneXpert diagnostic systems and related molecular testing solutions for...
- The U.S. Defense Department's Medical Supply Chain division awarded a $1,155 firm fixed-price delivery order to Cepheid Inc. on July 15, 2025, with an ultimate completion date of July 22, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. This delivery order represents a discrete procurement action for molecular diagnostic solutions, consistent with Cepheid's core business of manufacturing...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $15,400 on November 5, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, designated XPRSARS-COV2-10, is scheduled for completion by November 13, 2025, and involves the supply of diagnostic testing materials—specifically XPRS-COV2-10 cartridges for the company's GeneXpert diagnostic platform used to detect COVID-19 and other respiratory pathogens. The...
- The Defense Department's Medical Supply Chain agency awarded a $1,540 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, on September 3, 2025, with an ultimate completion date of September 10, 2025. The contract, designated XPRSARS-COV2-10, carries no set-aside designation and represents a delivery order likely issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts with the Department of Veterans...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $27,650.40 firm fixed-price delivery order to Cepheid Inc. on September 18, 2025, with completion targeted for September 25, 2025. The delivery order, identified as XPRSMVP-10 (Contract Number 4569505244), is being performed at Cepheid's headquarters in Sunnyvale, California. This award carries no set-aside designation and represents a discrete procurement under the company's broader federal contracting relationship with...
- The U.S. Defense Department's Medical Supply Chain division awarded a $19,375 firm fixed-price delivery order to Cepheid Inc. on September 8, 2025, with an ultimate completion date of September 15, 2025. This delivery order (XPRS4PLEX-10) represents a continuation of the federal government's ongoing procurement of molecular diagnostic solutions from the Sunnyvale, California-based manufacturer. The award carries no set-aside designation and is likely issued under one of Cepheid's existing...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,925 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The contract, designated XPRSARS-COV2-10, was executed on July 22, 2025, with a completion date of July 29, 2025, and carries no set-aside designation. This delivery order represents a continuation of the federal government's ongoing procurement of Cepheid's diagnostic testing capabilities, likely...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F480ADelivery Order
This delivery order, valued at $1,235.85, was awarded to Cepheid Inc. on November 25, 2025, by the Defense Logistics Agency Medical Supply Chain for diagnostic supplies supporting federal healthcare operations. The order, designated as XPRSARS-COV2-10, is structured as a firm fixed-price delivery order with no set-aside designation and is scheduled for completion by December 10, 2025. Performance will be executed at Cepheid's headquarters facility in Sunnyvale, California. This award represents a continuation of the company's established role as a primary federal supplier of molecular diagnostic testing solutions, particularly for respiratory pathogen detection including COVID-19. Cepheid, a manufacturer of advanced molecular diagnostic systems and reagents, has maintained an extensive federal contract portfolio spanning multiple agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard. The company holds two significant Indefinite Delivery Contracts with VA Veterans Integrated Service Networks, valued at $6.74 million and $32.8 million respectively, which serve as the primary procurement vehicles for diagnostic reagents and test kits across the VA healthcare system. This delivery order leverages Cepheid's established capabilities in providing GeneXpert diagnostic platform supplies and demonstrates the sustained federal demand for rapid molecular diagnostic testing solutions in military and veterans' healthcare settings.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/24/25 |